These findings are explained by an observational cohort study; osteoporosis in postmenopausal women may be due to their altered hormonal status, including estrogen and follicle-stimulating hormone (FSH), which are noted to be associated with obesity occurring in women (Ebong et al., 2022). Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.